Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2005
04/14/2005WO2004083816A3 Loss of heterozygosity of the dna markers in the 12q22-23 region
04/14/2005WO2004074506A3 Polynucleotide sequences and corresponding encoded polypeptides of particular secreted and membrane-bound proteins overexpressed in certain cancers
04/14/2005WO2004073624A3 Contraceptive methods and compositions related to proteasomal interference
04/14/2005WO2004070013A3 Use of islet 1 as a marker for isolating or generating stem cells
04/14/2005WO2004061616A3 Computer systems and methods for associating genes with traits using cross species data
04/14/2005WO2004060294A3 Functionalization of immobilized proteins
04/14/2005WO2004047767A3 Methods for identifying risk of breast cancer and treatments thereof
04/14/2005WO2004044140A3 2’-substituted oligomeric compounds and compositions for use in gene modulations
04/14/2005WO2004042347A3 Compositions and methods for detection and isolation of phosphorylated molecules
04/14/2005WO2004039307A3 Methods and compositions for diagnosing and treating companion animal cancer
04/14/2005WO2004037984A3 Nucleic acids, polypeptides, and methods for modulating apoptosis
04/14/2005WO2004037975A3 Composition and method for imaging cells
04/14/2005WO2004033656A3 Gene profiling of single or multiple cells
04/14/2005WO2004031105A3 Use of a33 antigens and jam-it
04/14/2005WO2004027376A3 Assay for ppar ligand dependent gene modulation
04/14/2005WO2004026266A3 SYNTHESIS AND APPLICATIONS OF TRINUCLEOTIDE pCpCpA-3′-NH-AMINOACYL DERIVATIVES
04/14/2005WO2004020580A3 Single nucleotide polymorphisms diagnostic for schizophrenia
04/14/2005WO2004013609A3 Use of biomarkers for detecting ovarian cancer
04/14/2005WO2004013347A3 Methods of identifying compounds that modulate protein activity
04/14/2005WO2004003232A8 Method for the characterisation of nucleic acid molecules
04/14/2005WO2003106617A3 Methods of detecting and treating prostate cancer
04/14/2005WO2003091277A3 Haplotypes of the cetp gene
04/14/2005WO2003073983A3 Methods and compositions in treating pain using diacylglycerol kinase epsilon
04/14/2005WO2003040340A3 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
04/14/2005WO2003040322A3 Promoters for regulation of gene expression in plant roots
04/14/2005WO2003027228A3 Receptors and membrane-associated proteins
04/14/2005WO2003002753A3 Diagnostic assays for parvovirus b19
04/14/2005US20050080232 Alzheimer's disease secretase, app substrates therefor, and uses therefor
04/14/2005US20050080032 Modulating expression of an endogenous marine invertebrate gene or an endogenous gene in a pathogen that infects marine invertebrate by administering to invertebrate at least one dsRNA that comprises a sequence having substantial sequence homology to the endogenous pathogen gene
04/14/2005US20050080026 Nucleic acid molecule of MAP kinase interacting kinase gene family or polypeptide encoded thereby or fragment or variant of nucleic acid molecule, polypeptide or antibody, aptamer or receptor recognizing a nucleic acid molecule of gene family or polypeptide encoded thereby; treating metabolic diseases
04/14/2005US20050080002 Methods for the treatment and prevention of cancer
04/14/2005US20050079995 For treatment of cancers through activation of silenced tumor suppressor genes, promotion of apoptosis in cancerous cells, and inhibition of transcriptional repressor activity in oncogenes; drug screening
04/14/2005US20050079634 comprises polytetrafluoroethylene substrate with radiation transparent glass/plastic covering; biochemical immobilization; for monitoring reactions or cell culture growth
04/14/2005US20050079598 Semiconductor substrate for use chip to chip and/or chip to standard genomic/gene expression analysis
04/14/2005US20050079596 Nitrite-oxidizing bacteria and methods of using and detecting the same
04/14/2005US20050079592 Device and method for manufacturing bead array, and method for detecting target substance
04/14/2005US20050079585 Complement depletion using recombinant human C3-derivatives
04/14/2005US20050079575 Human receptor molecules
04/14/2005US20050079572 Expression vector comprising nuclelotide sequences coding brain acid soluble protein 1 (BASP1) for use in prevention and treatment of infection, cell proliferative, inflammatory and autoimmune disorders; gene therapy; immunotherapeutics
04/14/2005US20050079570 Culture medium for rapid detection of mycobacterial growth by color change
04/14/2005US20050079569 Device which utilizes optical information to detect fermentative and non-fermentative microorganisms
04/14/2005US20050079568 Measuring protein kinase or phosphatase activity in a sample with a reporter peptide, or a fluorescently-labeled phosphorylatable reporter peptide, cleaved by a protease, without using antibodies or radioactive labels, bioassay
04/14/2005US20050079567 Modified luciferase
04/14/2005US20050079566 Analytical methods for determination of proteolytic cleavage at specific sites
04/14/2005US20050079565 Detecting and profiling molecular complexes
04/14/2005US20050079564 Test agents for evaluating pharmacological effect of drug and method and reagents for screening drug having excellent administration effect and/or little side effect from among drugs comprising enzymes, enzyme inhibitors or receptor ligands and/or prodrugs thereof
04/14/2005US20050079560 Detection and treatment of cancers of the colon
04/14/2005US20050079559 Antibodies specific for phosphorylation sites and screening methods using the same antibodies
04/14/2005US20050079554 Affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications
04/14/2005US20050079550 Isolated protein molecule, flh2882, a GPCR showing homology to the 5HT family of receptors
04/14/2005US20050079544 Automated method of metabolic stability analysis of library of compounds by isotope dilution mass spectrometry
04/14/2005US20050079543 direct interaction with the ligand-bound receptor and activation of one or more transcription factors; unaffected by the presence or concentration of second messengers; direct interaction with tyrosine kinase domains; absence of interaction with G-proteins; transcriptional stimulation of target genes
04/14/2005US20050079542 Wound monitoring
04/14/2005US20050079538 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; anticarcinogenic agents
04/14/2005US20050079537 Expression vector comprising nucleotide sequences coding membrane protein for in identifying modulator for prevention and treatment of cell proliferative, nervous system and inflammatory disorders
04/14/2005US20050079536 Generation of preferential nucleotide sequence pools; obtain nucleotide sequences, fragment, join to adaptors, digest, incubate with primers, amplify and recover nucleotide sequences
04/14/2005US20050079535 Isolating nucleic acid from solution via adsorption and desorption from substrates; bioanalytics; bioassay
04/14/2005US20050079534 Isolating vector from prokaryotic cells using short duration lysis, neutralization and filtration
04/14/2005US20050079532 Methods and systems for identifying predisposition to the placebo effect
04/14/2005US20050079531 Detection of 13Q14 chromosomal alterations
04/14/2005US20050079529 Using laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics
04/14/2005US20050079527 Bisulfite method
04/14/2005US20050079525 Long wavelength engineered fluorescent proteins
04/14/2005US20050079524 Manipulating, storing, modeling, visualizing and quantifying datasets for use in determining a genetic pathway in a population; genomics
04/14/2005US20050079523 Method of amplification
04/14/2005US20050079521 Using homogeneous primer mass extension to identify polymorphic loci associated with preferential gene sequences; genotyping; genetic mapping
04/14/2005US20050079520 Quantitating or detecting the presence of a plurality of different target molecules in a sample using detector molecules comprising nucleic acid tags
04/14/2005US20050079519 Using matrix composed of immobilized probed comprising 5'-acrylamide moiety to separate and identify preferential single stranded DNA molecules in electric field
04/14/2005US20050079518 Prediction of likelihood of cancer recurrence
04/14/2005US20050079517 Controlled evaporation, temperature control and packaging for optical inspection of biological samples
04/14/2005US20050079516 Chromosome stability assay
04/14/2005US20050079515 Compositions, splice variants and methods relating to breast specific nucleic acids and proteins
04/14/2005US20050079514 Method for the detection of Alzheimer's disease related gene transcripts in blood
04/14/2005US20050079513 Classification of patients having diffuse large B-cell lymphoma based upon gene expression
04/14/2005US20050079512 Using chromatin remodeling as diagnostic tool in detection of transcriptional regulators; gene expression analysis
04/14/2005US20050079510 Bead emulsion nucleic acid amplification
04/14/2005US20050079509 Methods for identifying suitable nucleic acid normalization probe sequences for use in nucleic acid arrays
04/14/2005US20050079508 Constraints-based analysis of gene expression data
04/14/2005US20050079507 Target evaluation using biological membrane arrays
04/14/2005US20050079506 support having disposed thereon at least one layer comprising filler and gelatin and a functional compound comprising a first functional group capable of interacting with gelatin and a second functional group capable of interacting with a biological capture agent
04/14/2005US20050079505 Electronically readable microarray with electronic addressing function
04/14/2005US20050079501 Using solid support comprising immobilized G-protein coding sequences as tool in detection and diagnosis of cell proliferative disorders
04/14/2005US20050079497 Generating microarray comprising at least two distinct nucleotide sequence probes for each target nucleic acid; gene expression analysis and genome complexity; probe matched target primers
04/14/2005US20050079496 Using nuclear factor of activated t-cells (nf-at) transcription factor expression as diagnostic tool detection and treatment of cell proliferative disorders
04/14/2005US20050079495 Modified membrane protein comprising proteolytic and is absent for g-protein coupling for use as tool in diagnosis, prevention and treatment of pain, arthritis, asthma, psychological and gastrointestinal disorders
04/14/2005US20050079494 Glycinin polypeptide for use as nutrient supplement in foods
04/14/2005US20050079493 DNA fingerprinting using allelic specific oligonucleotide reversed dot blot (ASO-RDB) flow through hybridization process and device
04/14/2005US20050079492 Using transcription factor direct target gene microarrays of both DNA and corresponding protein/peptide targets for assessing genetic and biochemical interaction profiles in sample populations; chromosomal immunoprecipation and cloning
04/14/2005US20050079491 Method for detecting and identifying the presence of biological substances derived from birds, and oligonucleotides therefor
04/14/2005US20050079490 Enriching ribosomal DNA or RNA in the sample by a Polymerase Chain Reaction method; quantifying and qualifying more rapidly than has previously been the case
04/14/2005US20050079489 Nested oligonucleotides containing a hairpin for nucleic acid amplification
04/14/2005US20050079487 Liquid crystals with reduced toxicity and applications thereof
04/14/2005US20050079486 Using liquid crystals to detect affinity microcontact printed biomolecules
04/14/2005US20050079485 Method to detect antibodies specific for type-2 turkey astrovirus
04/14/2005US20050079484 Using preferential biopolymer probes to detect biowarfare agents in drinking water
04/14/2005US20050079483 Novel method of diagnosing, monitoring, and staging prostate cancer
04/14/2005US20050079182 Immunogenic compositions of human papillomavirus and sera produced therefrom
04/14/2005US20050079172 An isolated cell that expresses an antibody binding to DR4 or DR5, two members of the tumor necrosis factor (TNF) receptor super family
04/14/2005US20050078860 Feature quantitation methods and system
04/14/2005US20050078179 Modulate aptamer and method for detecting target protein by using the same